🔗 Share this article

This year's prestigious award in medical science was granted for transformative findings that illuminate how the immune system targets dangerous pathogens while protecting the body's own cells.

A trio of renowned researchers—Japan's Prof. Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—received this accolade.

Their research identified unique "sentinels" within the immune system that eliminate malfunctioning defense cells that could harming the organism.

The discoveries are now enabling innovative therapies for immune disorders and cancer.

The winners will share a monetary award valued at 11m SEK.

Decisive Discoveries

"Their research has been decisive for understanding how the immune system operates and why we don't all develop serious autoimmune diseases," stated the chair of the award panel.

The team's research explain a core mystery: In what way does the defense system protect us from numerous infections while keeping our healthy cells intact?

The body's protection system employs immune cells that search for indicators of infection, even viruses and bacteria it has not met before.

These cells employ sensors—called receptors—that are produced randomly in a vast number of variations.

That gives the defense network the ability to combat a wide array of threats, but the unpredictability of the process inevitably creates immune cells that can target the body.

Security Guards of the Immune System

Researchers earlier knew that some of these harmful white blood cells were eliminated in the thymus—the site where immune cells develop.

This year's Nobel Prize honors the discovery of T-reg cells—known as the immune system's "security guards"—which travel through the body to disarm any immune cells that attack the healthy cells.

It is known that this mechanism fails in self-attack conditions such as juvenile diabetes, MS, and RA.

The prize committee stated, "These discoveries have laid the foundation for a novel area of research and spurred the creation of innovative therapies, for example for tumors and autoimmune diseases."

In cancer, regulatory T-cells prevent the system from attacking the growth, so studies are focused on lowering their quantity.

In self-attack disorders, trials are exploring increasing regulatory T-cells so the body is not under attack. A comparable method could also be effective in minimizing the chances of organ transplant failure.

Pioneering Experiments

Professor Shimon Sakaguchi, from Osaka University, conducted tests on rodents that had their thymus extracted, causing autoimmune disease.

The researcher demonstrated that injecting immune cells from healthy animals could stop the illness—suggesting there was a mechanism for preventing immune cells from attacking the host.

Dr. Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an genetic autoimmune disease in mice and humans that resulted in the discovery of a genetic factor vital for the way regulatory T-cells operate.

"Their pioneering research has revealed how the body's defenses is kept in check by T-reg cells, stopping it from mistakenly attacking the healthy cells," commented a leading biological science specialist.

"The research is a striking illustration of how fundamental biological study can have far-reaching consequences for public health."